Literature DB >> 7603467

Cholinergic inhibition of slow delayed-rectifier K+ current in guinea pig sino-atrial node is not mediated by muscarinic receptors.

L C Freeman1, R S Kass.   

Abstract

We studied the effects of cholinergic agonists on slow delayed-rectifier K+ current (IKs) in isolated cells from the sino-atrial node (SAN) region of guinea pig heart, using patch-clamp procedures. Carbachol (5 nM to 10 microM) inhibited IKs in guinea pig SAN cells in the absence of previous beta-adrenergic stimulation and in cells pretreated with 8-(4-chlorophenylthio)-cAMP. Neither the muscarinic antagonist atropine nor the nicotinic antagonist hexamethonium antagonized carbachol inhibition of the current. Similar results were obtained with other cholinergic agonists. Cholinergic stimulation of the muscarinic K+ current was successfully antagonized by atropine in SAN cells where inhibition of IKs persisted. Therefore, the lack of antagonist effects on inhibition of IKs cannot be attributed to either an absence of muscarinic cholinoceptors on SAN cells or a loss of antagonist activity under our experimental conditions. These data demonstrate that cholinergic agonists, including the endogenous neurotransmitter acetylcholine, decrease the amplitude of IKs in guinea pig SAN cells via a non-muscarinic, non-nicotinic, cAMP-independent mechanism. Although the precise nature of this signal transduction pathway has not been elucidated, it is clearly different from those described for regulation of other nodal currents. Differential regulation of IKs in guinea pig SAN and ventricle cannot be attributed to higher basal adenylate cyclase activity in SAN cells. The inhibitory effect of carbachol on IKs was not additive with that of verapamil, a drug that is both an allosteric muscarinic antagonist and a potassium channel-blocking agent. Cholinergic agonists may inhibit IKs in SAN cells via a direct interaction with the SAN IKs channel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603467

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.

Authors:  A A Selyanko; J K Hadley; I C Wood; F C Abogadie; T J Jentsch; D A Brown
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

2.  Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.

Authors:  M S Shapiro; J P Roche; E J Kaftan; H Cruzblanca; K Mackie; B Hille
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  Insights into the Regulatory Properties of Human Adenylyl Cyclase Type 9.

Authors:  Tanya A Baldwin; Yong Li; Cameron S Brand; Val J Watts; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

4.  Cyclical modulation of human ventricular repolarization by respiration.

Authors:  Ben Hanson; Jaswinder Gill; David Western; Michael P Gilbey; Julian Bostock; Mark R Boyett; Henggui Zhang; Ruben Coronel; Peter Taggart
Journal:  Front Physiol       Date:  2012-09-24       Impact factor: 4.566

5.  Regulation of IKs Potassium Current by Isoproterenol in Adult Cardiomyocytes Requires Type 9 Adenylyl Cyclase.

Authors:  Yong Li; Thomas Hof; Tanya A Baldwin; Lei Chen; Robert S Kass; Carmen W Dessauer
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

6.  Acetylcholine Reduces IKr and Prolongs Action Potentials in Human Ventricular Cardiomyocytes.

Authors:  István Koncz; Arie O Verkerk; Michele Nicastro; Ronald Wilders; Tamás Árpádffy-Lovas; Tibor Magyar; Noémi Tóth; Norbert Nagy; Micah Madrid; Zexu Lin; Igor R Efimov
Journal:  Biomedicines       Date:  2022-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.